performance liquid chromatography (HPLC) analyses were made on an Agilent 1200 series instrument equipped with a multi-wavelength UV-visible and a fluorescence detector.
Transmission electron microscopy (TEM) images were acquired using a Philips/FEI Tecnai 20 microscope. Gel permeation chromatographic (GPC) analyses were performed on Shimadzu LC20-AD prominence liquid chromatographer equipped with a refractive index detector and Waters columns; molecular weights were calculated using a conventional calibration curve constructed from narrow polystyrene standards using tetrahydrofuran (THF) as an eluent at a temperature of 40 °C. Cells were counted using Countess® automated cell counter procured from Invitrogen life technology. Plate reader analyses were performed on a Bio-Tek Synergy HT microplate reader. Dynamic light scattering (DLS) measurements were carried out using a Malvern Zetasizer Nano ZS system.
Methods.
Cell Lines and Cell Culture. RAW 264.7 cell line was procured from the American type culture collection (ATCC). These macrophages were grown at 37 °C in 5% CO 2 in Dulbecco's Modified Eagle's Medium (DMEM) supplemented with 1% L-glutamine, 1% sodium pyruvate, 1% penicillin/streptomycin, and 10% FBS. Cells were passed every 3 to 4 days and restarted from frozen stocks after 20 passages. (0.02 g, 0.170 mmol) were dissolved in dry dichloromethane and stirred for 30 min at 0 °C. A solution of DCC (0.106 g, 0.512 mmol) in dichloromethane was added drop wise to the reaction mixture. The reaction mixture was stirred form 0 °C to room temperature for 18 h.
Precipitated DCU by-product was filtered off and the solution was evaporated by rotavap.
This residue was resuspended by sonication in ethyl acetate and remaining DCU was removed. The solvent was evaporated and the resulting residue was dissolve in 5-10 mL of dichloromethane and precipitated with 40-45 mL of 1:1 mixture of methanol:diethylether and centrifuged. This process was repeated (5x) till the supernatant becomes clear solution. and stirred for 30 min at 0 °C. A solution of DCC (0.035 g, 0.170 mmol) in dichloromethane was added drop wise to the reaction mixture. This reaction mixture was stirred form 0 °C to room temperature for 18 h. The precipitated DCU by-product was filtered off and the solution was evaporated by rotavap to concentrate the volume to ~5 mL. The concentrated solution was then precipitated with 40-45 mL of cold diethyl ether and was centrifuged at 5000 RPM at 4 °C for 5 min. The resulting supernatant was decanted and the pellet was dissolved in 2-3 mL of CH 2 Cl 2 and 5 mL of methanol, 40 mL of diethyl ether was added to precipitate the product, and then centrifuged at the above settings. This process was repeated 3 times and the resulting pellet was lyophilized overnight to yield a white solid. Yield: 0.5 g, 96%.
1 H NMR ( Figure S4) T-Asp-and NT-Asp-NP Synthesis: Aspirin encapsulated targeted and non-targeted NPs were synthesized using the nanoprecipication method. Briefly, 100 µL from a 50 mg/mL CH 3 CN solution of PLGA-b-PEG-TPP for targeted or PLGA-b-PEG-OH polymer for nontargeted NPs, and 100 µL of a 10 mg/mL CH 3 CN solution of aspirin were added to 800 µL of CH 3 CN. This 1 mL solution was then added drop wise to 10 mL of vigorously stirring water and was allowed to stir for 2 h. The NPs formed were then filtered using Amicon filters with a molecular weight cut off of 100 kDa, washed three times with nanopure water, and the NPs were resuspended in nanopure water at a concentration of 5 mg/mL. The size and surface charge of the NPs were characterized using dynamic light scattering method ( Figure S6 ). three times with 100 mL of 10% Na 2 CO 3 , three times with 100 mL of 10% NaHSO 4 and three times with 100 mL of brine. The resulting solution was dried over MgSO 4 . This was then filtered using a glass filter, and remaining solvent was evaporated. The crude product was purified by silica flash chromatography (silica packed with hexanes) using ethylacetate:hexanes (5:95) solvent gradient to yield an oil as a product. Yield 3.7 g (56%). then washed three times with 50 mL of 1 M NaHCO 3 , three times with 50 mL of 10% NaHSO 4 , and three times with 50 mL of brine. The final solution was dried over MgSO 4 to remove any remaining water. The solvent was then evaporated to yield an oil. The crude product was then purified using silica flash column chromatography (silica packed with hexanes) using ethylacetate:hexane (10:90) and then ethylacetate:hexane (15:85), and the product was isolated as a pale yellow oil. Yield: 947 mg, 87%.
H NMR (Figure S7
1 H NMR ( Figure S16) The solvent was then evaporated to yield an oil. The crude product was then purified using silica flash column chromatography (silica packed with hexanes) using ethylacetate:hexane (10:90), then ethylacetate:hexane (20:80), and the product was isolated as an oil. Yield: 1.83 g, 44%.
1 H NMR ( Figure S19) 
Synthesis and characterization of Oc-[G2]-(OH) 4 (8):

Oc-[G2]-(OH) 4 (8)
( Figure S22) of the concentrated product was checked by thin layer chromatography (TLC). The product showed two spots on TLC. This crude product was then purified using silica flash column (packed with CH 2 Cl 2 ) initially with methanol:dichloromethane (0.5:99.5) and then methanol:dichloromethane (1:99). The solvent was evaporated to yield a pale yellow oil. Yield 1.2 g, 87%.
Synthesis and Characterization of Oc-[G2]-(Asp
1 H NMR ( Figure S25) 
Aspirin Quantification in NPs:
The amount of aspirin encapsulated in the synthesized NPs was quantified using HPLC. To create the standard curves for aspirin, Oc-[G1]-(Asp) 2 , or Oc-
[G2]-(Asp) 4 , 800 µL of a 1 mg/mL solution was created, and then serial dilutions were done to create 400 µL solutions with concentration of 1000 µg/mL, 500 µg/mL, 250 µg/mL, 125 µg/mL, 62.5 µg/mL, 31.25 µg/mL, 15.625 µg/mL, and 7.8125 µg/mL. To these solutions, 100
µL of 0.1 M NaOH solution and 100 µL of water were added for a total volume of 600 µL. To prepare the samples for analysis, 400 µL of CH 3 CN, 100 µL of 0.1 M NaOH, and 100 µL of the synthesized NPs were added. These solutions were then incubated at 37 °C, for 24 h, and then analyzed using an Agilent 1260 Infinity series HPLC system. The mobile phase used was 50:50 CH 3 CN:water. Aspirin was converted to salicylic acid, which produces a peak at approximately 12.5 min at 295 nm wavelength. The peak areas of the samples were obtained and using the prepared standard curve the aspirin concentration in the NPs were calculated. coated plates using 10% FBS in PBS for 1 h at room temperature followed by 3 washes. The serum samples (20 µL) or standard were incubated on the plates for 2 h at room temperature followed by several washing steps and serial incubations with the cytokine-biotin conjugate and streptavidin working solution. ELISA was finally followed by using a colorimetric assay by adding the substrate reagent containing 3,3',5,5'-tetramethylbenzidine (100 µL) to each well and incubation got 15 min, the reaction was then stopped by using 50 µL H 2 SO 4 (2N). The absorbance of the product formed was recorded at 450 nm using a BioTek Synergy HT well plate reader. 
Release of Aspirin from T-(
